Article By:
The Fly
Saturday, March 26, 2022 1:15 PM EDT
Shares of AN2 Therapeutics rose over 15% in its trading debut on Friday following an upsized initial public offering. This was only the second initial public offering this month, as the IPO market seems to be on pause due to the war in Ukraine.
